Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeri Kim

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Cancer Research|September 6, 2005
16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathwaySok-Hyong Lee, Michiya Nishino, Tuhina Mazumdar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinicLydia T Madsen, Deborah A Kuban, Seungtaek Choi, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapyMehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2018
Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative researchMuammer Altok, Bumyang Kim, Bina B Patel, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
European Urology Oncology|August 22, 2022
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate CancerJustin R Gregg, Jeri Kim, Christopher Logothetis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.
JAMA Internal Medicine|July 16, 2014
Physician variation in management of low-risk prostate cancer: a population-based cohort studyKaren E Hoffman, Jiangong Niu, Yu Shen, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Cancer Research|September 6, 2005
16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathwaySok-Hyong Lee, Michiya Nishino, Tuhina Mazumdar, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinicLydia T Madsen, Deborah A Kuban, Seungtaek Choi, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapyMehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.
Prostate Cancer and Prostatic Diseases|July 11, 2018
Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative researchMuammer Altok, Bumyang Kim, Bina B Patel, et al.
The Journal of Biological Chemistry|February 27, 2004
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activityThomas R Salas, Jeri Kim, Funda Vakar-Lopez, et al.
European Urology Oncology|August 22, 2022
Coffee Intake, Caffeine Metabolism Genotype, and Survival Among Men with Prostate CancerJustin R Gregg, Jeri Kim, Christopher Logothetis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.
JAMA Internal Medicine|July 16, 2014
Physician variation in management of low-risk prostate cancer: a population-based cohort studyKaren E Hoffman, Jiangong Niu, Yu Shen, et al.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
BJU International|July 16, 2017
Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancerSpyridon P Basourakos, John W Davis, Brian F Chapin, et al.
Pageof 11